With this partnership, Grane Rx becomes a premier pharmacy partner on the CareHub network, offering access to innovative features and a collaboration to bring to market capabilities our customers need.
Tardive dyskinesia (TD) affects approximately 600,000 people in the United States. In an effort to raise awareness of TD, states are being asked to declare May 5-11, 2024 as TD Awareness Week.
having a knowledgeable and proactive pharmacy partner can make all the difference when it comes to delivering quality long-term care.
Whether you’re looking to move away from a one size fits all approach to your prescribing practices or reduce costs and negative outcomes associated with trial-and-error prescribing, incorporating a pharmacogenetics test into your treatment model is a increasingly reliable means of getting better results and healthier patients.
Pharmacogenomics testing (PGx) can be an incredibly valuable tool for your care delivery.
Jen Devinney, Chief Clinical Officer at Grane Rx and Rick Shigaki, VP Pharmaceutical Solutions at Access Dx provide a detailed overview of the applications for pharmacogenomics testing across a variety of care settings. Watch the webinar replay originally hosted by Center for Healthcare Solutions.
Is your LTC pharmacy services provider doing everything they can?